Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Correction to: Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.

Ohata Y, Takeyari S, Nakano Y, Kitaoka T, Nakayama H, Bizaoui V, Yamamoto K, Miyata K, Yamamoto K, Fujiwara M, Kubota T, Michigami T, Yamamoto K, Yamamoto T, Namba N, Ebina K, Yoshikawa H, Ozono K.

Osteoporos Int. 2020 Apr 3. doi: 10.1007/s00198-020-05396-y. [Epub ahead of print]

PMID:
32246166
2.

Clinical Practice Guidelines for Hypophosphatasia.

Michigami T, Ohata Y, Fujiwara M, Mochizuki H, Adachi M, Kitaoka T, Kubota T, Sawai H, Namba N, Hasegawa K, Fujiwara I, Ozono K.

Clin Pediatr Endocrinol. 2020;29(1):9-24. doi: 10.1297/cpe.29.9. Epub 2020 Jan 9.

3.

Orientation analysis of pentacene molecules in organic field-effect transistor devices using polarization-dependent Raman spectroscopy.

Bhardwaj BS, Sugiyama T, Namba N, Umakoshi T, Uemura T, Sekitani T, Verma P.

Sci Rep. 2019 Oct 22;9(1):15149. doi: 10.1038/s41598-019-51647-2.

4.

Ultralow-Noise Organic Transistors Based on Polymeric Gate Dielectrics with Self-Assembled Modifiers.

Kondo M, Uemura T, Ishiwari F, Kajitani T, Shoji Y, Morita M, Namba N, Inoue Y, Noda Y, Araki T, Fukushima T, Sekitani T.

ACS Appl Mater Interfaces. 2019 Nov 6;11(44):41561-41569. doi: 10.1021/acsami.9b13056. Epub 2019 Oct 22.

PMID:
31594305
5.

IGF2 Mutations.

Masunaga Y, Inoue T, Yamoto K, Fujisawa Y, Sato Y, Kawashima-Sonoyama Y, Morisada N, Iijima K, Ohata Y, Namba N, Suzumura H, Kuribayashi R, Yamaguchi Y, Yoshihashi H, Fukami M, Saitsu H, Kagami M, Ogata T.

J Clin Endocrinol Metab. 2020 Jan 1;105(1). pii: dgz034. doi: 10.1210/clinem/dgz034.

PMID:
31544945
6.

Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.

Ohata Y, Takeyari S, Nakano Y, Kitaoka T, Nakayama H, Bizaoui V, Yamamoto K, Miyata K, Yamamoto K, Fujiwara M, Kubota T, Michigami T, Yamamoto K, Yamamoto T, Namba N, Ebina K, Yoshikawa H, Ozono K.

Osteoporos Int. 2019 Nov;30(11):2333-2342. doi: 10.1007/s00198-019-05076-6. Epub 2019 Jul 29. Erratum in: Osteoporos Int. 2020 Apr 3;:.

7.

Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.

Mizuguchi C, Nakagawa M, Namba N, Sakai M, Kurimitsu N, Suzuki A, Fujita K, Horiuchi S, Baba T, Ohgita T, Nishitsuji K, Saito H.

J Biol Chem. 2019 Sep 6;294(36):13515-13524. doi: 10.1074/jbc.RA119.008000. Epub 2019 Jul 24.

PMID:
31341020
8.

DNA Methylation Status of SHOX-Flanking CpG Islands in Healthy Individuals and Short Stature Patients with Pseudoautosomal Copy Number Variations.

Ogushi K, Hattori A, Suzuki E, Shima H, Izawa M, Yagasaki H, Horikawa R, Uetake K, Umezawa A, Ishii T, Muroya K, Namba N, Tanaka T, Hirano Y, Yamamoto H, Soneda S, Matsubara K, Kagami M, Miyado M, Fukami M.

Cytogenet Genome Res. 2019;158(2):56-62. doi: 10.1159/000500468. Epub 2019 Jun 4.

9.

Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.

Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA.

Lancet. 2019 Jun 15;393(10189):2416-2427. doi: 10.1016/S0140-6736(19)30654-3. Epub 2019 May 16. Erratum in: Lancet. 2019 Jul 13;394(10193):120.

PMID:
31104833
10.

Taming chlorophylls by early eukaryotes underpinned algal interactions and the diversification of the eukaryotes on the oxygenated Earth.

Kashiyama Y, Yokoyama A, Shiratori T, Hess S, Not F, Bachy C, Gutierrez-Rodriguez A, Kawahara J, Suzaki T, Nakazawa M, Ishikawa T, Maruyama M, Wang M, Chen M, Gong Y, Seto K, Kagami M, Hamamoto Y, Honda D, Umetani T, Shihongi A, Kayama M, Matsuda T, Taira J, Yabuki A, Tsuchiya M, Hirakawa Y, Kawaguchi A, Nomura M, Nakamura A, Namba N, Matsumoto M, Tanaka T, Yoshino T, Higuchi R, Yamamoto A, Maruyama T, Yamaguchi A, Uzuka A, Miyagishima S, Tanifuji G, Kawachi M, Kinoshita Y, Tamiaki H.

ISME J. 2019 Aug;13(8):1899-1910. doi: 10.1038/s41396-019-0377-0. Epub 2019 Feb 26.

11.

Raman Spectroscopic Studies of Dinaphthothienothiophene (DNTT).

Bhardwaj BS, Sugiyama T, Namba N, Umakoshi T, Uemura T, Sekitani T, Verma P.

Materials (Basel). 2019 Feb 18;12(4). pii: E615. doi: 10.3390/ma12040615.

12.

Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis.

Namba N, Kawasaki A, Sada KE, Hirano F, Kobayashi S, Yamada H, Furukawa H, Shimada K, Hashimoto A, Matsui T, Nagasaka K, Sugihara T, Suzuki A, Yamagata K, Sumida T, Tohma S, Homma S, Ozaki S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N; Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS).

Ann Rheum Dis. 2019 Aug;78(8):1144-1146. doi: 10.1136/annrheumdis-2018-214263. Epub 2019 Feb 14. No abstract available.

PMID:
30765393
13.

Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report.

Takeyari S, Takakuwa S, Miyata K, Yamamoto K, Nakayama H, Ohata Y, Fujiwara M, Kitaoka T, Kubota T, Namba N, Sakai N, Ozono K.

Clin Pediatr Endocrinol. 2019;28(1):1-7. doi: 10.1297/cpe.28.1. Epub 2019 Jan 31.

14.

Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.

Islam MS, Namba N, Ohata Y, Fujiwara M, Nakano C, Takeyari S, Miyata K, Nakano Y, Yamamoto K, Nakayama H, Kitaoka T, Kubota T, Ozono K.

Endocr J. 2019 Jan 28;66(1):19-29. doi: 10.1507/endocrj.EJ18-0251. Epub 2018 Oct 25.

15.

A case of perinatal hypophosphatasia with a novel mutation in the ALPL gene: clinical course and review of the literature.

Oyachi M, Harada D, Sakamoto N, Ueyama K, Kondo K, Kishimoto K, Izui M, Nagamatsu Y, Kashiwagi H, Yamamuro M, Tamura M, Kikuchi S, Akiyama T, Michigami T, Seino Y, Namba N.

Clin Pediatr Endocrinol. 2018;27(3):179-186. doi: 10.1297/cpe.27.179. Epub 2018 Jul 31.

16.

Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.

Akiyama T, Kubota T, Ozono K, Michigami T, Kobayashi D, Takeyari S, Sugiyama Y, Noda M, Harada D, Namba N, Suzuki A, Utoyama M, Kitanaka S, Uematsu M, Mitani Y, Matsunami K, Takishima S, Ogawa E, Kobayashi K.

Mol Genet Metab. 2018 Sep;125(1-2):174-180. doi: 10.1016/j.ymgme.2018.07.006. Epub 2018 Jul 17.

PMID:
30049651
17.

Endocrinological and phenotype evaluation in a patient with acrodysostosis.

Ueyama K, Namba N, Kitaoka T, Yamamoto K, Fujiwara M, Ohata Y, Kubota T, Ozono K.

Clin Pediatr Endocrinol. 2017;26(3):177-182. doi: 10.1297/cpe.26.177. Epub 2017 Jul 27.

18.

Final adult height in long-term growth hormone-treated achondroplasia patients.

Harada D, Namba N, Hanioka Y, Ueyama K, Sakamoto N, Nakano Y, Izui M, Nagamatsu Y, Kashiwagi H, Yamamuro M, Ishiura Y, Ogitani A, Seino Y.

Eur J Pediatr. 2017 Jul;176(7):873-879. doi: 10.1007/s00431-017-2923-y. Epub 2017 May 13.

19.

Renewable Wood Pulp Paper Reactor with Hierarchical Micro/Nanopores for Continuous-Flow Nanocatalysis.

Koga H, Namba N, Takahashi T, Nogi M, Nishina Y.

ChemSusChem. 2017 Jun 22;10(12):2560-2565. doi: 10.1002/cssc.201700576. Epub 2017 May 4.

20.

Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves' disease.

Yasuda K, Miyoshi Y, Tachibana M, Namba N, Miki K, Nakata Y, Takano T, Ozono K.

Clin Pediatr Endocrinol. 2017 Jan;26(1):1-7. doi: 10.1297/cpe.26.1. Epub 2017 Jan 31.

21.

Pheochromocytoma complicated by cyanotic congenital heart disease: a case report.

Yamamoto K, Namba N, Kubota T, Usui T, Takahashi K, Kitaoka T, Fujiwara M, Hori Y, Kogaki S, Oue T, Morii E, Ozono K.

Clin Pediatr Endocrinol. 2016 Apr;25(2):59-65. doi: 10.1297/cpe.25.59. Epub 2016 Apr 28.

22.

Three novel mutations of the MCT8 (SLC16A2) gene: individual and temporal variations of endocrinological and radiological features.

Ono E, Ariga M, Oshima S, Hayakawa M, Imai M, Ochiai Y, Mochizuki H, Namba N, Ozono K, Miyata I.

Clin Pediatr Endocrinol. 2016 Apr;25(2):23-35. doi: 10.1297/cpe.25.23. Epub 2016 Apr 28.

23.

Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.

Fujiwara M, Kubota T, Wang W, Ohata Y, Miura K, Kitaoka T, Okuzaki D, Namba N, Michigami T, Kitabatake Y, Ozono K.

Bone. 2016 Apr;85:91-8. doi: 10.1016/j.bone.2016.01.024. Epub 2016 Feb 2.

PMID:
26851122
24.

Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.

Kubota T, Wang W, Miura K, Nakayama H, Yamamoto K, Fujiwara M, Ohata Y, Tachibana M, Kitaoka T, Takakuwa S, Miyoshi Y, Namba N, Ozono K.

Clin Endocrinol (Oxf). 2016 Jun;84(6):845-50. doi: 10.1111/cen.13025. Epub 2016 Feb 25.

PMID:
26814021
25.

[FGF23 related hypophosphatemic rickets:current therapy and unresolved issues].

Harada D, Namba N.

Clin Calcium. 2016 Feb;26(2):269-76. doi: CliCa1602269276. Review. Japanese.

PMID:
26813507
26.

Acromesomelic dysplasia, type maroteaux caused by novel loss-of-function mutations of the NPR2 gene: Three case reports.

Wang W, Song MH, Miura K, Fujiwara M, Nawa N, Ohata Y, Kitaoka T, Kubota T, Namba N, Jin DK, Kim OH, Ozono K, Cho TJ.

Am J Med Genet A. 2016 Feb;170A(2):426-434. doi: 10.1002/ajmg.a.37463. Epub 2015 Nov 14.

PMID:
26567084
27.

Detection of Hereditary 1,25-Hydroxyvitamin D-Resistant Rickets Caused by Uniparental Disomy of Chromosome 12 Using Genome-Wide Single Nucleotide Polymorphism Array.

Tamura M, Isojima T, Kawashima M, Yoshida H, Yamamoto K, Kitaoka T, Namba N, Oka A, Ozono K, Tokunaga K, Kitanaka S.

PLoS One. 2015 Jul 8;10(7):e0131157. doi: 10.1371/journal.pone.0131157. eCollection 2015.

28.

Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.

Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, Yamauchi M, Sugimoto T, Minagawa M, Michigami T, Nagai M, Matsumoto T.

Endocr J. 2015;62(9):811-6. doi: 10.1507/endocrj.EJ15-0275. Epub 2015 Jul 1.

29.

Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets.

Kubota T, Kitaoka T, Miura K, Fujiwara M, Ohata Y, Miyoshi Y, Yamamoto K, Takeyari S, Yamamoto T, Namba N, Ozono K.

Horm Res Paediatr. 2014;81(4):251-7. doi: 10.1159/000357142. Epub 2014 Feb 26.

PMID:
24577200
30.

Therapeutic use of oral sodium phosphate (phosribbon(®) combination granules) in hereditary hypophosphatemic rickets.

Ozono K, Hasegawa Y, Minagawa M, Adachi M, Namba N, Kazukawa I, Kitaoka T, Asakura Y, Shimura A, Naito Y.

Clin Pediatr Endocrinol. 2014 Jan;23(1):9-15. doi: 10.1292/cpe.23.9. Epub 2014 Feb 3.

31.

Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.

Ohata Y, Yamazaki M, Kawai M, Tsugawa N, Tachikawa K, Koinuma T, Miyagawa K, Kimoto A, Nakayama M, Namba N, Yamamoto H, Okano T, Ozono K, Michigami T.

J Bone Miner Res. 2014 Jul;29(7):1627-38. doi: 10.1002/jbmr.2186.

32.

Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literature.

Kitaoka T, Miyoshi Y, Namba N, Miura K, Kubota T, Ohata Y, Fujiwara M, Takagi M, Hasegawa T, Jüppner H, Ozono K.

Eur J Pediatr. 2014 Jun;173(6):799-804. doi: 10.1007/s00431-013-2252-8. Epub 2014 Jan 4. Review.

PMID:
24390061
33.

Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.

Miura K, Kim OH, Lee HR, Namba N, Michigami T, Yoo WJ, Choi IH, Ozono K, Cho TJ.

Am J Med Genet A. 2014 Jan;164A(1):156-63. doi: 10.1002/ajmg.a.36218. Epub 2013 Nov 20.

PMID:
24259409
34.

Treatment of Hypophosphatemic Rickets with Phosphate and Active Vitamin D in Japan: A Questionnaire-based Survey.

Fujiwara M, Namba N, Ozono K, Arisaka O, Yokoya S; Committee on Drugs, Japanese Society for Pediatric Endocrinology*.

Clin Pediatr Endocrinol. 2013 Jan;22(1):9-14. doi: 10.1292/cpe.22.. Epub 2013 Feb 7.

35.

Detection and characterization of two novel mutations in the HNF4A gene in maturity-onset diabetes of the young type 1 in two Japanese families.

Fujiwara M, Namba N, Miura K, Kitaoka T, Hirai H, Kondou H, Shimotsuji T, Numakura C, Ozono K.

Horm Res Paediatr. 2013;79(4):220-6. doi: 10.1159/000350520. Epub 2013 May 1.

PMID:
23652628
36.

Pediatric aspects of skeletal dysplasia.

Ozono K, Namba N, Kubota T, Kitaoka T, Miura K, Ohata Y, Fujiwara M, Miyoshi Y, Michigami T.

Pediatr Endocrinol Rev. 2012 Oct;10 Suppl 1:35-43. Review.

PMID:
23330244
37.

Low serum concentrations of anti-Müllerian hormone are common in 53 female childhood cancer survivors.

Miyoshi Y, Ohta H, Namba N, Tachibana M, Miyamura T, Miyashita E, Hashii Y, Oue T, Isobe A, Tsutsui T, Kimura T, Ozono K.

Horm Res Paediatr. 2013;79(1):17-21. doi: 10.1159/000346139. Epub 2012 Dec 28.

PMID:
23295306
38.

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.

Miura K, Namba N, Fujiwara M, Ohata Y, Ishida H, Kitaoka T, Kubota T, Hirai H, Higuchi C, Tsumaki N, Yoshikawa H, Sakai N, Michigami T, Ozono K.

PLoS One. 2012;7(8):e42180. doi: 10.1371/journal.pone.0042180. Epub 2012 Aug 3.

39.

Monocarboxylate transporter 10 functions as a thyroid hormone transporter in chondrocytes.

Abe S, Namba N, Abe M, Fujiwara M, Aikawa T, Kogo M, Ozono K.

Endocrinology. 2012 Aug;153(8):4049-58. doi: 10.1210/en.2011-1713. Epub 2012 Jun 19.

PMID:
22719050
40.

Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23.

Narazaki R, Ihara K, Namba N, Matsuzaki H, Ozono K, Hara T.

Pediatr Nephrol. 2012 May;27(5):861-3. doi: 10.1007/s00467-011-2086-4. Epub 2011 Dec 29.

PMID:
22205508
41.

[Perimenarchial growth spurt of the bone].

Namba N, Ozono K.

Clin Calcium. 2011 Sep;21(9):1315-21. doi: CliCa110913151321. Review. Japanese.

PMID:
21881193
42.

A Male Patient with Humoral Hypercalcemia of Malignancy (HHM) with Leukocytosis Caused by Cutaneous Squamous Cell Carcinoma Resulting from Recessive Dystrophic Epidermolysis Bullosa.

Miura K, Umegaki N, Kitaoka T, Kubota T, Namba N, Etani Y, Hirai H, Kogaki S, Nakajima S, Takahashi Y, Tamai K, Katayama I, Ozono K.

Clin Pediatr Endocrinol. 2011 Jul;20(3):65-71. doi: 10.1297/cpe.20.65. Epub 2011 Oct 7.

43.

Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood.

Ohata Y, Arahori H, Namba N, Kitaoka T, Hirai H, Wada K, Nakayama M, Michigami T, Imura A, Nabeshima Y, Yamazaki Y, Ozono K.

J Clin Endocrinol Metab. 2011 Jun;96(6):E943-7. doi: 10.1210/jc.2010-2357. Epub 2011 Mar 16.

PMID:
21411554
44.

Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta.

Kitaoka T, Namba N, Miura K, Kubota T, Ohata Y, Fujiwara M, Hirai H, Yamamoto T, Ozono K.

J Bone Miner Metab. 2011 Sep;29(5):598-605. doi: 10.1007/s00774-011-0262-z. Epub 2011 Feb 23.

PMID:
21344299
45.

[Genetic basis for skeletal disease. Nosology and molecular classification of skeletal dysplasias].

Namba N.

Clin Calcium. 2010 Aug;20(8):1159-65. doi: CliCa100811591165. Review. Japanese.

PMID:
20675925
46.

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects.

Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y.

Biochem Biophys Res Commun. 2010 Jul 30;398(3):513-8. doi: 10.1016/j.bbrc.2010.06.110. Epub 2010 Jul 1.

47.

Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cells.

Namba N, Matsuo K, Kubonishi S, Kikuchi T, Maeda Y, Niiya M, Shinagawa K, Koide N, Ikeda K, Tanimoto M.

Transfusion. 2009 Nov;49(11):2384-9. doi: 10.1111/j.1537-2995.2009.02314.x. Epub 2009 Jul 17.

PMID:
19624602
48.

A Japanese male patient with 'fibular aplasia, tibial campomelia and oligodactyly': an additional case report.

Kitaoka T, Namba N, Kim JY, Kubota T, Miura K, Miyoshi Y, Hirai H, Kogo M, Ozono K.

Clin Pediatr Endocrinol. 2009 Jul;18(3):81-6. doi: 10.1297/cpe.18.81. Epub 2009 Aug 1.

49.

Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism.

Bessho K, Etani Y, Ichimori H, Miyoshi Y, Namba N, Yoneda A, Ooue T, Chihara T, Morii E, Aoki T, Murakami M, Mushiake S, Ozono K.

Eur J Pediatr. 2010 Feb;169(2):215-21. doi: 10.1007/s00431-009-1009-x. Epub 2009 Jun 23.

PMID:
19548001
50.

Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.

Kobayashi K, Maeda Y, Hara Y, Nishie-Kataoka M, Nishimori H, Sugiyama H, Namba N, Kubonishi S, Niiya M, Shinagawa K, Ikeda K, Tanimoto M.

Anticancer Res. 2009 May;29(5):1763-70.

Supplemental Content

Support Center